Experimental assessments of intrafractional prostate motion on sequential and simultaneous boost to a dominant intraprostatic lesion

Medical Physics

Volumn 39, Issue 3, 2012, Pages 1505-1517

  Abdellatif, Ady ^a   Craig, Jeff ^b   Jensen, Michael ^a   Mulligan, Matt ^b   Mosalaei, Homeira ^b   Bauman, Glenn ^a,b   Chen, Jeff ^a,b   Wong, Eugene ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

DIL boost; IMRT; prostate intrafractional motion; VMAT

Indexed keywords

COMPUTERIZED TOMOGRAPHY; QUALITY ASSURANCE; QUALITY CONTROL; RADIOTHERAPY; UROLOGY;

DIL BOOST; EXPERIMENTAL ASSESSMENT; IMRT; INTENSITY-MODULATED RADIATION THERAPY; INTRAFRACTIONAL MOTION; REAL-TIME LOCALIZATION; VMAT; VOLUMETRIC MODULATED ARC THERAPY;

TIME AND MOTION STUDY;

PERU TOMATO MOSAIC VIRUS;

EID: 84863294340     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3685586     Document Type: Article

References (46)

1. G. Groenendaal, Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients., Radiother. Oncol. 95, 185-190 (2010). 10.1016/j.radonc.2010.02.014
2. J. Scheidler, Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging-Clinicopathologic study., Radiology 213, 473-480 (1999).
3. F. A. Van Dorsten, Combined quantitative dynamic contrast-enhanced MR imaging an 1H NMR spectroscopic imaging of human prostate cancer., J. Magn. Reson Imaging 20, 279-287 (2004). 10.1002/(ISSN)1522-2586
4. J. J. Fütterer, Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging., Radiology 241, 449-458 (2006). 10.1148/radiol.2412051866
5. K. Hosseinzadeh and S. D. Schwarz, Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue., J. Magn. Reson Imaging 20, 654-661 (2004). 10.1002/(ISSN)1522-2586
6. H. Miao, H. Fukatsu, and T. Ishigaki, Prostate cancer detection with 3-T MRI: Comparison of diffusion-weighted and T2-weighted imaging., Eur. J. Radiol. 61, 297-302 (2007). 10.1016/j.ejrad.2006.10.002
7. H. Park, Validation of automatic target volume definition as demonstrated for (11)C-Choline PET/CT of human prostate cancer using multi modality fusion techniques., Acad. Radiol. 17 (5), 614-623 (2010). 10.1016/j.acra.2010.01.003
8. M. Pinkawa, Dose-escalation using intensity-modulated radiotherapy for prostate cancer-Evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost., Radiother. Oncol. 93 (2), 213-219 (2009). 10.1016/j.radonc.2009.07.014
9. A. Pollack, Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial., Int. J. Radiat. Oncol., Biol., Phys. 53 (5), 1097-1105 (2002). 10.1016/S0360-3016(02)02829-8
10. A. L. Zietman, Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial., JAMA, J. Am. Med. Assoc. 294 (10), 1233-1239 (2005). 10.1001/jama.294.10.1233
11. D. P. Dearnaley, Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects., Br. J. Cancer 92 (3), 488-498 (2005). 10.1038/sj.bjc.6602624
12. S. T. Peeters, Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy., J. Clin. Oncol. 24 (13), 1990-1996 (2006). 10.1200/JCO.2005.05.2530
13. P. Xia, Forward or intensity planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy., Int. J. Radiat. Oncol., Biol., Phys. 51, 244-254 (2001). 10.1016/S0360-3016(01)01643-1
14. A. K. Singh, Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: Early results of a phase I NCI study., Radiat. Oncol. 2, 36 (2007). 10.1186/1748-717X-2-36
15. R. Shaffer, Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: A planning comparison study., Clin. Oncol. 21, 401-407 (2009). 10.1016/j.clon.2009.01.014
16. B. Pickett, Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimentsional radiotherapy., Int. J. Radiat. Oncol., Biol., Phys. 43, 921-929 (1999). 10.1016/S0360-3016(98)00456-8
17. M. Gaudet, Dose escalation to the dominant intraprostatic lesion defined by sextant biopsy in a permanent prostate I-125 implant: A prospective comparative toxicity analysis., Int. J. Radiat. Oncol., Biol., Phys. 77 (1), 153-159 (2010). 10.1016/j.ijrobp.2009.04.049
18. K. H. Cho, Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas., Int. J. Radiat. Oncol., Biol., Phys. 78 (2), 390-397 (2010). 10.1016/j.ijrobp.2009.08.029
19. E. Orlandi, Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review., Crit. Rev. Oncol. Hematol. 73 (2), 111-125 (2010). 10.1016/j.critrevonc.2009.03.003
20. L. A. Dawson, A comparison of ventilatory prostate movement in four treatment positions., Int. J. Radiat. Oncol., Biol., Phys. 48, 319-323 (2000). 10.1016/S0360-3016(00)00751-3
21. K. Kitamura, Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions., Int. J. Radiat. Oncol., Biol., Phys. 53, 1117-1123 (2002). 10.1016/S0360-3016(02)02882-1
22. T. R. Willoughby, Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer., Int. J. Radiat. Oncol., Biol., Phys. 65, 528-534 (2006). 10.1016/j.ijrobp.2006.01. 050
23. H. Chen, A. Wu, and E. Brandner, Dosimetric evaluations of the interplay effect in respiratory-gated intensity-modulated radiation therapy., Med. Phys. 36 (6), 2340 (2009). 10.1118/1.3132483
24. H. Li, I. Chetty, and T. Solberg, Quantifying the interplay effect in prostate IMRT delivery using a convolution-based method., Med. Phys. 35 (5), 1703-1710 (2008). 10.1118/1.2897972
25. M. Schaefer, Influence of intra-fractional breathing movement in step-and-shoot IMRT., Phys. Med. Biol. 49 (12), N175-N179 (2004). 10.1088/0031-9155/49/12/N03
26. P. A. Kupelian, Multi-institutional clinical experience with the Calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy., Int. J. Radiat. Oncol., Biol., Phys. 67, 1088-1098 (2007). 10.1016/j.ijrobp.2006.10.026
27. T. Craig, Impact of geometric uncertainties on evaluation of treatment techniques for prostate cancer., Int. J. Radiat. Oncol., Biol., Phys. 62 (2), 426-436 (2005). 10.1016/j.ijrobp.2004.09.016
28. D. Maleike, J. Unkelbach, and U. Oelfke, Simulation and visualization of dose uncertainties due to interfractional organ motion., Phys. Med. Biol. 51 (9), 2237-2252 (2006). 10.1088/0031-9155/51/9/009
29. S. Hossain, Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT., Med. Phys. 35 (9), 4041-4048 (2008). 10.1118/1.2968333
30. H. Li, Dosimetric consequences of intrafraction prostate motion., Int. J. Radiat. Oncol., Biol., Phys. 71 (3), 801-812 (2008). 10.1016/j.ijrobp.2007.10. 049
31. E. D. Ehler, B. E. Nelms, and W. A. Tomé, On the dose to a moving target while employing different IMRT delivery mechanisms., Radiother. Oncol. 83 (1), 49-56 (2007). 10.1016/j.radonc.2007.02.007
32. D. Rangaraj, G. Palaniswaamy, and L. Papiez, DMLC IMRT delivery to targets moving in 2D in beam's eye view., Med. Phys. 35 (8), 3765-3778 (2008). 10.1118/1.2952775
33. D. McQuaid and S. Webb, IMRT delivery to a moving target by dynamic MLC tracking: Delivery for targets moving in two dimensions in the beam's eye view., Phys. Med. Biol. 51 (19), 4819-4839 (2006). 10.1088/0031-9155/51/19/007
34. R. McMahon, A real-time dynamic-MLC control algorithm for delivering IMRT to targets undergoing 2D rigid motion in the beam's eye view., Med. Phys. 35 (9), 3875-3888 (2008). 10.1118/1.2963987
35. J. A. Purdy, Dose to normal tissues outside the radiation therapy patient's treated volume: A review of different radiation therapy techniques., Health Phys. 95 (5), 666-676 (2008). 10.1097/01.HP.0000326342.47348.06
36. M. E. Chen, Detailed mapping of prostate carcinoma foci: Biopsy strategy implications., Cancer 89, 1800-1809 (2000). 10.1002/(ISSN)1097-0142
37. P. A. Jursinic Angular dependence of dose sensitivity of surface diodes., Med. Phys. 36 (6), 2165-2171 (2009). 10.1118/1.3125644
38. D. Low, A technique for the quantitative evaluation of dose distributions., Med. Phys. 25 (5), 656-661 (1998). 10.1118/1.598248
39. MapPHAN™ Rotational Dosimetry datasheet, Sun Nuclear Corporation, Melbourne, Florida.
40. F. B. Buonamici, An intercomparison between film dosimetry and diode matrix for IMRT quality assurance., Med. Phys. 34 (4), 1372-1379 (2007). 10.1118/1.2713426
41. H. Mosalaei, The use of intensity-modulated radiation therapy photon beams for improving the dose uniformity of electron beams shaped with MLC., Med. Dosim. (in press).
42. MapCHECK™ Software manual, Sun Nuclear Corporation, Melbourne, Florida.
43. J. J. Kruse, On the insensitivity of single field planar dosimetry to IMRT inaccuracies., Med. Phys. 37 (6), 2516-2524 (2010). 10.1118/1.3425781
44. B. E. Nelms, H. Zhen H, and W. A. Tomé, Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors., Med. Phys. 38 (2), 1037-1044 (2011). 10.1118/1.3544657
45. 95, Med Phys. 38 (8), 4505-4511 (2011). 10.1118/1.3605633
46. H. Zhen, B. E. Nelms, and W. A. Tomé, WE-C-BRB-12: Moving from gamma based to patient DVH based IMRT QA., Med. Phys. 38 (6), 3806 (2011). 10.1118/1.3613331